You May Also Like

NIOSH Conformity Assessment Letter to Manufacturers, CA 2020-1031 - Effective Immediately – In response to COVID-19 – UPDATED NIOSH prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing approval holders, new domestic manufacturers/applicants, and new international manufacturers/applicants. Supersedes NIOSH CA 2020-1027. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notice: CA-2021-1032
Cite
CITE Title : NIOSH Conformity Assessment Letter to Manufacturers, CA 2020-1031 - Effective Immediately – In response to COVID-19 – UPDATED NIOSH prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing approval holders, new domestic manufacturers/applicants, and new international manufacturers/applicants. Supersedes NIOSH CA 2020-1027. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notice: CA-2021-1032 Published Date : 08/21/2020 URL : https://stacks.cdc.gov/view/cdc/137553 "NIOSH Conformity Assessment Letter" (2020). "NIOSH Conformity Assessment Letter to Manufacturers, CA 2020-1031 - Effective Immediately – In response to COVID-19 – UPDATED NIOSH prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing approval holders, new domestic manufacturers/applicants, and new international manufacturers/applicants. Supersedes NIOSH CA 2020-1027. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notice: CA-2021-1032" (2020) "NIOSH Conformity Assessment Letter to Manufacturers, CA 2020-1031 - Effective Immediately – In response to COVID-19 – UPDATED NIOSH prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing approval holders, new domestic manufacturers/applicants, and new international manufacturers/applicants. Supersedes NIOSH CA 2020-1027. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notice: CA-2021-1032" , 2020 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 152.08 KB]
08/21/2020 | NIOSH
Description:
In response to the nation’s effort to control the spread of coronavirus disease 2019 (COVID-19), the National Institute for Occupational Safety and ...
File Type:
[PDF - 152.08 KB]
File Type:
[PDF - 152.08 KB]

NIOSH Conformity Assessment Letter to Manufacturers, CA 2021-1032 - Effective Immediately – In response to COVID-19 – Updated NIOSH fraud and fraudulent statements policy and prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing domestic and non-domestic approval holders, new domestic manufacturers/applicants, and new non-domestic manufacturers/applicants. Supersedes NIOSH CA 2020-1031. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notices: CA-2022-1041 and CA-2022-1040.
Cite
CITE Title : NIOSH Conformity Assessment Letter to Manufacturers, CA 2021-1032 - Effective Immediately – In response to COVID-19 – Updated NIOSH fraud and fraudulent statements policy and prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing domestic and non-domestic approval holders, new domestic manufacturers/applicants, and new non-domestic manufacturers/applicants. Supersedes NIOSH CA 2020-1031. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notices: CA-2022-1041 and CA-2022-1040. Published Date : 02/25/2022 URL : https://stacks.cdc.gov/view/cdc/137554 "NIOSH Conformity Assessment Letter" (2022). "NIOSH Conformity Assessment Letter to Manufacturers, CA 2021-1032 - Effective Immediately – In response to COVID-19 – Updated NIOSH fraud and fraudulent statements policy and prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing domestic and non-domestic approval holders, new domestic manufacturers/applicants, and new non-domestic manufacturers/applicants. Supersedes NIOSH CA 2020-1031. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notices: CA-2022-1041 and CA-2022-1040." (2022) "NIOSH Conformity Assessment Letter to Manufacturers, CA 2021-1032 - Effective Immediately – In response to COVID-19 – Updated NIOSH fraud and fraudulent statements policy and prioritization for accepting and examining particulate filtering respirator approval applications, including Surgical N95 respirators, submitted by existing domestic and non-domestic approval holders, new domestic manufacturers/applicants, and new non-domestic manufacturers/applicants. Supersedes NIOSH CA 2020-1031. This notice has been superseded. For the latest NIOSH guidance on this topic, please see the updated notices: CA-2022-1041 and CA-2022-1040." , 2022 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 193.04 KB]
02/25/2022 | NIOSH
Description:
NIOSH issued an earlier version of this Conformity Assessment Letter to Manufacturers (CA 2020-1031) in August 2020 to address the overwhelming number...
File Type:
[PDF - 193.04 KB]
File Type:
[PDF - 193.04 KB]